Biodistribution, pharmacokinetics and microSPECT/CT imaging of 188Re-BMEDA-liposome in a C26 murine colon carcinoma solid tumor animal model

Anticancer Research

Volumn 27, Issue 4 B, 2007, Pages 2217-2225

  Chang, Ya Jen ^a   Chang, Chih Hsien ^a   Chang, Tsui Jung ^a   Yu, Chia Yu ^a   Chen, Liang Cheng ^a   Jan, Meei Lin ^a   Luo, Tsai Yueh ^a   Lee, Te Wei ^a   Ting, Gann ^b,c  

^a INSTITUTE OF NUCLEAR ENERGY RESEARCH   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

188Re; Biodistribution; microSPECT CT; Nanoliposome; Pharmacokinetics; Rhenium 188

Indexed keywords

LIPOSOME; N,N BIS(2 MERCAPTOETHYL) N',N' DIETHYLETHYLENEDIAMINE RE 188; RADIOISOTOPE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; COLON CARCINOMA; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION COEFFICIENT; DRUG DISTRIBUTION; DRUG UPTAKE; IMAGE ANALYSIS; MALE; MOUSE; MUSCLE; NONHUMAN; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ANIMALS; CELL LINE, TUMOR; COLONIC NEOPLASMS; DISEASE MODELS, ANIMAL; DRUG STABILITY; ETHYLENEDIAMINES; ISOTOPE LABELING; LIPOSOMES; MALE; MICE; MICE, INBRED BALB C; ORGANOMETALLIC COMPOUNDS; RADIOISOTOPES; RADIOPHARMACEUTICALS; RHENIUM; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 34547773740     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Allen TM and Cullis PR: Drug delivery systems: entering the mainstream. Science 303: 1818-1822, 2004.
2. Torchilin VP: Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov 4: 145-160, 2005.
3. Sessa G and Weissmann G: Phospholipid spherules (liposomes) as a model for biological membranes. J Lipid Res 9: 310-318, 1968.
4. Fahr A, van Hoogevest P, Kuntsche J and Leigh ML: Lipophilic drug transfer between liposomal and biological membranes: what does it mean for parenteral and oral drug delivery? J Liposome Res 16: 281-301, 2006.
5. Weissig V, Boddapati SV, Cheng SM and D'Souza GG: Liposomes and liposome-like vesicles for drug and DNA delivery to mitochondria. J Liposome Res 16: 249-264, 2006.
6. Gabizon AA, Lyass O, Berry GJ and Wildgust M: Cardiac safety of pegylated liposomal doxorubicin (Doxil/Caelyx) demonstrated by endomyocardial biopsy in patients with advanced malignancies. Cancer Invest 22: 663-669, 2004.
7. Gabizon A, Shmeeda H, Horowitz AT and Zalipsky S: Tumor cell targeting of liposome-entrapped drugs with phospholipid-anchored folic acid-PEG conjugates. Adv Drug Deliv Rev 56: 1177-1192, 2004.
8. Alberts DS, Muggia FM, Carmichael J, Winer EP, Jahanzeb M, Venook AP, Skubitz KM, Rivera E, Sparano JA, DiBella NJ, Stewart SJ, Kavanagh JJ and Gabizon AA: Efficacy and safety of liposomal anthracyclines in phase I/II clinical trials. Semin Oncol 31: 53-90, 2004.
9. Drummond M, Dubois D, Garattini L, Horisberger B, Jonsson B, Kristiansen IS, Le Pen C, Pinto CG, Poulsen PB, Rovira J, Rutten F, von der Schulenburg MG and Sintonen H: Current trends in the use of pharmacoeconomics and outcomes research in europe. Value Health 2: 323-332, 1999.
10. Carmona-Ribeiro AM: Lipid bilayer fragments and disks in drug delivery. Curr Med Chem 13: 1359-1370, 2006.
11. Kshirsagar NA, Pandya SK, Kirodian GB and Sanath S: Liposomal drug delivery system from laboratory to clinic. J Postgrad Med 51(Suppl 1): S5-15, 2005.
12. Hong RL, Huang CJ, Tseng YL, Pang VF, Chen ST, Liu JJ and Chang FH: Direct comparison of liposomal doxorubicin with or without polyethylene glycol coating in C-26 tumor-bearing mice: is surface coating with polyethylene glycol beneficial? Clin Cancer Res 5: 3645-3652, 1999.
13. Gabizon A, Shmeeda H and Barenholz Y: Pharmacokinetics of pegylated liposomal Doxorubicin: review of animal and human studies. Clin Pharmacokinet 42: 419-436, 2003.
14. 186Re-SNS/S complexes: in vitro stability, imaging, and biodistribution in rats. J Nucl Med 44: 1992-1999, 2003.
15. Keng GH and Sundram FX: Radionuclide therapy of hepatocellular carcinoma. Ann Acad Med Singapore 32: 518-524, 2003.
16. Mastrostamatis SG, Papadopoulos MS, Pirmettis IC, Paschali E, Varvarigou AD, Stassinopoulou CI, Raptopoulou CP, Terzis A and Chiotellis E: Tridentate ligands containing the SNS donor atom set as a novel backbone for the development of technetium brain-imaging agents. J Med Chem 37: 3212-3218, 1994.
17. Massoud TF and Gambhir SS: Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev 17: 545-580, 2003.
18. 111In-DTPA- labelled pegylated liposomes in a human tumour xenograft model: implications for novel targeting strategies. Br J Cancer 83: 232-238, 2000.
19. 99mTc-"SNS/S" complexes: in vitro and in vivo evaluation. J Pharm Sci 92: 1893-1904, 2003.
20. Goins BA and Phillips WT: The use of scintigraphic imaging as a tool in the development of liposome formulations. Prog Lipid Res 40: 95-123, 2001.
21. 99mTc-labeled liposomes encapsulating blue dye for identification of the sentinel lymph node. J Nucl Med 42: 446-451, 2001.
22. Hallahan DE, Qu S, Geng L, Cmelak A, Chakravarthy A, Martin W, Scarfone C and Giorgio T: Radiation-mediated control of drug delivery. Am J Clin Oncol 24: 473-480, 2001.
23. 177Lu-labeled monoclonal antibody MN-14 to carcinoembryonic antigen in mice with small peritoneal metastases of colorectal origin. J Nucl Med 45: 1224-1232, 2004.
24. 111In-dTPA-labelled pegylated liposomes after intraperitoneal injection. Acta Oncol 42: 147-153, 2003.
25. Chang CH, Wang HE, Wu SY, Fan KH, Tsai TH, Lee TW, Chang SR, Liu RS, Chen CF, Chen CH and Fu YK: Comparative evaluation of FET and FDG for differentiating lung carcinoma from inflammation in mice. Anticancer Res 26: 917-925, 2006.
26. 188Re generators. Appl Radiat Isot 47: 23-26, 1996.
27. Tseng YL, Hong RL, Tao MH and Chang FH: Sterically stabilized anti-idiotype immunoliposomes improve the therapeutic efficacy of doxorubicin in a murine B-cell lymphoma model. Int J Cancer 80: 723-730, 1999.
28. Bartlett GR: Phosphorus assay in column chromatography. J Biol Chem 234: 466-468, 1959.
29. Kesner AL, Dahlbom M, Huang SC, Hsueh WA, Pio SB, Czernin J, Kreissl M, Wu HM and Silverman DH: Semiautomated analysis of small-animal PET data. J Nucl Med 47: 1181-1186, 2006.
30. Meirelles GS, Kijewski P and Akhurst T: Correlation of PET/CT standardized uptake value measurements between dedicated workstations and a PACS-integrated workstation system. J Digit Imaging 0: 1-7, 2006.
31. Safra T, Groshen S, Jeffers S, Tsao-Wei DD, Zhou L, Muderspach L, Roman L, Morrow CP, Burnett A and Muggia FM: Treatment of patients with ovarian carcinoma with pegylated liposomal doxorubicin: analysis of toxicities and predictors of outcome. Cancer 91: 90-100, 2001.
32. Harrington KJ, Mohammadtaghi S, Uster PS, Glass D, Peters AM, Vile RG and Stewart JS: Effective targeting of solid tumors in patients with locally advanced cancers by radiolabeled pegylated liposomes. Clin Cancer Res 7: 243-254, 2001.
33. Lim HJ, Masin D, McIntosh NL, Madden TD and Bally MB: Role of drug release and liposome-mediated drug delivery in governing the therapeutic activity of liposomal mitoxantrone used to treat human A431 and LS180 solid tumors. J Pharmacol Exp Ther 292: 337-345, 2000.
34. 111In-DTPA- labelled pegylated liposomes in a human tumour xenograft model. Br J Cancer 83: 684-688, 2000.
35. Jain RK: Delivery of molecular and cellular medicine to solid tumors. Adv Drug Deliv Rev 26: 71-90, 1997.
36. Bao A, Phillips WT, Goins B, Zheng X, Sabour S, Natarajan M, Ross Woolley F, Zavaleta C and Otto RA: Potential use of drug-carried-liposomes for cancer therapy via direct intratumoral injection. Int J Pharm 316: 162-169, 2006.
37. Macklis RM and Pohlman B: Radioimmunotherapy for non-Hodgkin's lymphoma: a review for radiation oncologists. Int J Radiat Oncol Biol Phys 66: 833-841, 2006.